Samson Kinyanjui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Samson Kinyanjui has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Agnetor Kakungu
KEMRI-Wellcome Trust
2 shared publications - Anna Färnert
Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Billy Ngasala
Department of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences , Dar es Salaam
2 shared publications - Charles Nyaigoti Agoti
KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research
2 shared publications Daniel Langat
Affiliation Division of Disease Surveillance and Response, Ministry of Health, Nairobi, Kenya
2 shared publications- Doreen David Mutemi
Division of Infectious Diseases, Department of Medicine, Karolinska Institutet , Solna
2 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (3) , e0006011
Cholera in Kenya: A scoping review of current research, evidence gaps and future directions
Cholera remains a major public health challenge in Kenya, driven by environmental pollution, poor water, sanitation, and hygiene (WASH) facilities, weak monitoring systems, and climate effects. While there have been improvements in studying the disease, testing, monitoring, and environmental checks, the spread continues, especially in informal settlements, rural areas, and refugee camps. This review looked at 106 peer-reviewed studies published between 1979 and 2024. It aimed to describe the scope, progress, and gaps in cholera research in Kenya. Five databases, including Google Scholar, Web of Science, PubMed, Embase, and Scopus, were searched using the terms “cholera” and “Kenya.” Titles and abstracts were reviewed using Rayyan, and data were collected using a standard form that noted study goals, methods, findings, limitations, and geographic coverage. The evidence was analysed thematically, and trends were tracked over time. Among 845 records found, 106 met the criteria for inclusion. The literature consistently connects cholera outbreaks in Kenya to climate events like flooding, drought, and El Niño, with greater vulnerability seen in informal settlements and refugee areas. Surveillance systems are still disconnected, often leading to delays in reporting and limited information at sub-county levels. Assessments of the health system reveal ongoing issues, including a shortage of laboratory resources and necessary tests. Despite innovations such as rapid diagnostic tests, whole-genome sequencing, and spatial modelling that have enhanced outbreak detection and understanding of transmission, their regular use is hindered by cost, infrastructure, and workforce issues. Social and behavioural factors, such as low-risk perception and gaps between knowledge and practice, also contribute to continued transmission. In summary, controlling cholera in Kenya needs a coordinated, multi-faceted approach. This should focus on strengthening surveillance, improving WASH facilities, increasing laboratory and molecular capabilities, expanding vaccine access, and fostering community-led efforts to turn scientific progress into effective public health measures.
- 31 March 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (3) , e0006011
Open AccessCholera in Kenya: A scoping review of current research, evidence gaps and future directions
Cholera remains a major public health challenge in Kenya, driven by environmental pollution, poor water, sanitation, and hygiene (WASH) facilities, weak monitoring systems, and climate effects. While there have been improvements in studying the disease, testing, monitoring, and environmental checks, the spread continues, especially in informal settlements, rural areas, and refugee camps. This review looked at 106 peer-reviewed studies published between 1979 and 2024. It aimed to describe the scope, progress, and gaps in cholera research in Kenya. Five databases, including Google Scholar, Web of Science, PubMed, Embase, and Scopus, were searched using the terms “cholera” and “Kenya.” Titles and abstracts were reviewed using Rayyan, and data were collected using a standard form that noted study goals, methods, findings, limitations, and geographic coverage. The evidence was analysed thematically, and trends were tracked over time. Among 845 records found, 106 met the criteria for inclusion. The literature consistently connects cholera outbreaks in Kenya to climate events like flooding, drought, and El Niño, with greater vulnerability seen in informal settlements and refugee areas. Surveillance systems are still disconnected, often leading to delays in reporting and limited information at sub-county levels. Assessments of the health system reveal ongoing issues, including a shortage of laboratory resources and necessary tests. Despite innovations such as rapid diagnostic tests, whole-genome sequencing, and spatial modelling that have enhanced outbreak detection and understanding of transmission, their regular use is hindered by cost, infrastructure, and workforce issues. Social and behavioural factors, such as low-risk perception and gaps between knowledge and practice, also contribute to continued transmission. In summary, controlling cholera in Kenya needs a coordinated, multi-faceted approach. This should focus on strengthening surveillance, improving WASH facilities, increasing laboratory and molecular capabilities, expanding vaccine access, and fostering community-led efforts to turn scientific progress into effective public health measures.
- Open Access
Cholera in Kenya: a scoping review of current research, evidence gaps and future directions
Background: Cholera remains a major public health issue in Kenya, driven by environmental pollution, poor sanitation, poor surveillance, and sporadic climate shocks. The disease continues, particularly in underprivileged areas and refugee camps, despite scientific developments, particularly in molecular surveillance and environmental monitoring. Objectives: This scoping review sought to map peer-reviewed literature on cholera in Kenya published until October 2024. The emphasis is on assessing epidemiological patterns, transmission dynamics, surveillance efficacy, clinical management, and advancements, including molecular tools. Eligibility Criteria: Studies were included if they were peer-reviewed, published in English, focused on cholera in Kenya, and addressed one or more domains aligned with the Kenya National Multisectoral Cholera Elimination Plan (NMCEP) 2022-2030, namely, leadership and coordination, case management, surveillance, water, sanitation, and hygiene (WASH), risk communication, or oral cholera vaccination. Studies unrelated to cholera, outside the Kenyan context, or inaccessible were excluded. Sources of Evidence: Using the terms cholera AND Kenya , five databases (Google Scholar, Web of Science, PubMed, Embase, and Scopus) were systematically searched. Of the 845 records found, 106 studies were included following an eligibility assessment and screening process. Charting Methods: Rayyan was used to screen titles and abstracts. A standardised form capturing study goals, methodology, results, gaps, and geographic coverage was used to extract data. Trends were mapped, and research needs were found through thematic synthesis. Results: The studies revealed that El Niño episodes and drought situations aggravate cholera hotspots in urban informal settlements and refugee camps. Though they face cost and scale-up challenges, innovations like rapid diagnostics and whole genome sequencing (WGS) show promise. Sociocultural obstacles, inadequate laboratory equipment, and fragmented surveillance networks hinder control initiatives. Conclusions: Controlling cholera in Kenya requires an integrated, multisectoral strategy aligned with the National Multisectoral Cholera Elimination Plan (NMCEP) 2022-2030. This includes strengthening molecular surveillance, improving WASH systems, enhancing laboratory and diagnostic capacity, and supporting community-driven initiatives. Sustainable cholera prevention will depend on bridging the gap between scientific innovation and real-world implementation through predictive modelling, coordinated planning, and culturally informed health education.
Open AccessCholera in Kenya: a scoping review of current research, evidence gaps and future directions
Background: Cholera remains a major public health issue in Kenya, driven by environmental pollution, poor sanitation, poor surveillance, and sporadic climate shocks. The disease continues, particularly in underprivileged areas and refugee camps, despite scientific developments, particularly in molecular surveillance and environmental monitoring. Objectives: This scoping review sought to map peer-reviewed literature on cholera in Kenya published until October 2024. The emphasis is on assessing epidemiological patterns, transmission dynamics, surveillance efficacy, clinical management, and advancements, including molecular tools. Eligibility Criteria: Studies were included if they were peer-reviewed, published in English, focused on cholera in Kenya, and addressed one or more domains aligned with the Kenya National Multisectoral Cholera Elimination Plan (NMCEP) 2022-2030, namely, leadership and coordination, case management, surveillance, water, sanitation, and hygiene (WASH), risk communication, or oral cholera vaccination. Studies unrelated to cholera, outside the Kenyan context, or inaccessible were excluded. Sources of Evidence: Using the terms cholera AND Kenya , five databases (Google Scholar, Web of Science, PubMed, Embase, and Scopus) were systematically searched. Of the 845 records found, 106 studies were included following an eligibility assessment and screening process. Charting Methods: Rayyan was used to screen titles and abstracts. A standardised form capturing study goals, methodology, results, gaps, and geographic coverage was used to extract data. Trends were mapped, and research needs were found through thematic synthesis. Results: The studies revealed that El Niño episodes and drought situations aggravate cholera hotspots in urban informal settlements and refugee camps. Though they face cost and scale-up challenges, innovations like rapid diagnostics and whole genome sequencing (WGS) show promise. Sociocultural obstacles, inadequate laboratory equipment, and fragmented surveillance networks hinder control initiatives. Conclusions: Controlling cholera in Kenya requires an integrated, multisectoral strategy aligned with the National Multisectoral Cholera Elimination Plan (NMCEP) 2022-2030. This includes strengthening molecular surveillance, improving WASH systems, enhancing laboratory and diagnostic capacity, and supporting community-driven initiatives. Sustainable cholera prevention will depend on bridging the gap between scientific innovation and real-world implementation through predictive modelling, coordinated planning, and culturally informed health education.
- Open Access
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission
Malaria transmission intensity affects the development of naturally acquired immunity to malaria. An absolute correlate measure of protection against malaria is lacking. However, antibody-mediated functions against Plasmodium falciparum correlate with protection against malaria. In children, antibody-mediated functions against P. falciparum decline with reduced exposure. It is unclear whether adults maintain antibody-mediated functions as malaria transmission declines. This study assessed antibody-dependent respiratory burst (ADRB) in individuals from an area with declining malaria transmission. In an age-matched analysis, we compare ADRB activity during high versus low malaria transmission periods. Age significantly predicted higher ADRB activity in the high (p < 0.001) and low (p < 0.001) malaria transmission periods. ADRB activity was higher during the high compared to the low malaria transmission period in older children and adults. Only older adults during the high malaria transmission period had their median ADRB activity above the ADRB cut-off. Ongoing P. falciparum infection influenced ADRB activity during the low (p = 0.01) but not the high (p = 0.29) malaria transmission period. These findings propose that naturally acquired immunity to P. falciparum is affected in children and adults as malaria transmission declines, implying that vaccines will be necessary to induce and maintain protection against malaria.
Open AccessAntibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission
Malaria transmission intensity affects the development of naturally acquired immunity to malaria. An absolute correlate measure of protection against malaria is lacking. However, antibody-mediated functions against Plasmodium falciparum correlate with protection against malaria. In children, antibody-mediated functions against P. falciparum decline with reduced exposure. It is unclear whether adults maintain antibody-mediated functions as malaria transmission declines. This study assessed antibody-dependent respiratory burst (ADRB) in individuals from an area with declining malaria transmission. In an age-matched analysis, we compare ADRB activity during high versus low malaria transmission periods. Age significantly predicted higher ADRB activity in the high (p < 0.001) and low (p < 0.001) malaria transmission periods. ADRB activity was higher during the high compared to the low malaria transmission period in older children and adults. Only older adults during the high malaria transmission period had their median ADRB activity above the ADRB cut-off. Ongoing P. falciparum infection influenced ADRB activity during the low (p = 0.01) but not the high (p = 0.29) malaria transmission period. These findings propose that naturally acquired immunity to P. falciparum is affected in children and adults as malaria transmission declines, implying that vaccines will be necessary to induce and maintain protection against malaria.
- Open Access
- 18 January 2024
- Published by MDPI AG in Preprints.org
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission
Malaria transmission intensity affects the development of naturally acquired immunity to malaria. An absolute correlate of protection against malaria is lacking. However, anti-body-mediated functions against P. falciparum correlate with protection against malaria. In children, antibody-mediated functions against P. falciparum generally decline with a reduction in exposure; however, it is unclear whether adults maintain antibody-mediated functions in the context of re-duced exposure. This study assessed antibody-dependent respiratory burst (ADRB) in individuals from an area with declining malaria transmission. In an age-matched analysis, we compare ADRB activity during high versus low malaria transmission periods. Age significantly predicted higher ADRB activity in both the high and low malaria transmission periods. Within all age categories, ADRB activity was higher during the high compared to the low malaria transmission period, with only the adults during the high malaria transmission period having their mean ADRB activity above the ADRB cut-off. Interestingly, ongoing P. falciparum infection influenced ADRB activity during the low but not the high malaria transmission period. These findings propose that naturally acquired immunity to P. falciparum is affected in children and adults as malaria transmission declines, im-plying that vaccines will be necessary to induce and maintain protection against malaria.
- 18 January 2024
- Published by MDPI AG in Preprints.org
Open AccessAntibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission
Malaria transmission intensity affects the development of naturally acquired immunity to malaria. An absolute correlate of protection against malaria is lacking. However, anti-body-mediated functions against P. falciparum correlate with protection against malaria. In children, antibody-mediated functions against P. falciparum generally decline with a reduction in exposure; however, it is unclear whether adults maintain antibody-mediated functions in the context of re-duced exposure. This study assessed antibody-dependent respiratory burst (ADRB) in individuals from an area with declining malaria transmission. In an age-matched analysis, we compare ADRB activity during high versus low malaria transmission periods. Age significantly predicted higher ADRB activity in both the high and low malaria transmission periods. Within all age categories, ADRB activity was higher during the high compared to the low malaria transmission period, with only the adults during the high malaria transmission period having their mean ADRB activity above the ADRB cut-off. Interestingly, ongoing P. falciparum infection influenced ADRB activity during the low but not the high malaria transmission period. These findings propose that naturally acquired immunity to P. falciparum is affected in children and adults as malaria transmission declines, im-plying that vaccines will be necessary to induce and maintain protection against malaria.
- Open Access
- 3 October 2022
- Published by BMJ in BMJ Global Health
- Vol. 7 (10) , e009472
A framework for managing health research capacity strengthening consortia: addressing tensions and enhancing capacity outcomes
There has been a steady increase in health research capacity strengthening (HRCS) consortia and programmes. However, their structures and management practices and the effect on the capacity strengthening outcomes have been underexamined. We conducted a case study involving three HRCS consortia where we critically examined the consortia’s decision-making processes, strategies for resolving management tensions and the potential implications for consortia outcomes. We conducted 44 in-depth interviews with a range of consortia members and employed the framework method to analyse the data. We assessed the extent to which consortia’s management practices and strategies enabled or hindered research capacity strengthening using a capacity development lens. At the heart of consortium management is how tensions are navigated and the resolution strategies adopted. This study demonstrates that the management strategies adopted by consortia have capacity strengthening consequences. When deciding on tension management strategies, trade-offs often occur, sometimes to the detriment of capacity strengthening aims. When management strategies align with capacity development principles, consortium management processes become capacity strengthening mechanisms for participating individuals and institutions. Such alignment enhances programme effectiveness and value for money. Drawing on these findings, we propose an evidence-informed management framework that consortia leaders can use in practice to support decision-making to optimise research capacity gains. Considering the increasing investment in HRCS consortia, leveraging all consortium processes towards capacity strengthening will maximise the returns on investments made.
- 3 October 2022
- Published by BMJ in BMJ Global Health
- Vol. 7 (10) , e009472
Open AccessA framework for managing health research capacity strengthening consortia: addressing tensions and enhancing capacity outcomes
There has been a steady increase in health research capacity strengthening (HRCS) consortia and programmes. However, their structures and management practices and the effect on the capacity strengthening outcomes have been underexamined. We conducted a case study involving three HRCS consortia where we critically examined the consortia’s decision-making processes, strategies for resolving management tensions and the potential implications for consortia outcomes. We conducted 44 in-depth interviews with a range of consortia members and employed the framework method to analyse the data. We assessed the extent to which consortia’s management practices and strategies enabled or hindered research capacity strengthening using a capacity development lens. At the heart of consortium management is how tensions are navigated and the resolution strategies adopted. This study demonstrates that the management strategies adopted by consortia have capacity strengthening consequences. When deciding on tension management strategies, trade-offs often occur, sometimes to the detriment of capacity strengthening aims. When management strategies align with capacity development principles, consortium management processes become capacity strengthening mechanisms for participating individuals and institutions. Such alignment enhances programme effectiveness and value for money. Drawing on these findings, we propose an evidence-informed management framework that consortia leaders can use in practice to support decision-making to optimise research capacity gains. Considering the increasing investment in HRCS consortia, leveraging all consortium processes towards capacity strengthening will maximise the returns on investments made.
- Open Access
- 30 May 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 894770
Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study
Background: Plasmodium falciparum variant surface antigens (VSAs) contribute to malaria pathogenesis by mediating cytoadhesion of infected red blood cells to the microvasculature endothelium. In this study, we investigated the association between anti-VSA antibodies and clinical outcome in a controlled human malaria infection (CHMI) study.Method: We used flow cytometry and ELISA to measure levels of IgG antibodies to VSAs of five heterologous and one homologous P. falciparum parasite isolates, and to two PfEMP1 DBLβ domains in blood samples collected a day before the challenge and 14 days after infection. We also measured the ability of an individual’s plasma to inhibit the interaction between PfEMP1 and ICAM1 using competition ELISA. We then assessed the association between the antibody levels, function, and CHMI defined clinical outcome during a 21-day follow-up period post infection using Cox proportional hazards regression.Results: Antibody levels to the individual isolate VSAs, or to two ICAM1-binding DBLβ domains of PfEMP1, were not associated with a significantly reduced risk of developing parasitemia or of meeting treatment criteria after the challenge after adjusting for exposure. However, anti-VSA antibody breadth (i.e., cumulative response to all the isolates) was a significant predictor of reduced risk of requiring treatment [HR 0.23 (0.10-0.50) p= 0.0002].Conclusion: The breadth of IgG antibodies to VSAs, but not to individual isolate VSAs, is associated with protection in CHMI.
- 30 May 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 894770
Open AccessBreadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study
Background: Plasmodium falciparum variant surface antigens (VSAs) contribute to malaria pathogenesis by mediating cytoadhesion of infected red blood cells to the microvasculature endothelium. In this study, we investigated the association between anti-VSA antibodies and clinical outcome in a controlled human malaria infection (CHMI) study.Method: We used flow cytometry and ELISA to measure levels of IgG antibodies to VSAs of five heterologous and one homologous P. falciparum parasite isolates, and to two PfEMP1 DBLβ domains in blood samples collected a day before the challenge and 14 days after infection. We also measured the ability of an individual’s plasma to inhibit the interaction between PfEMP1 and ICAM1 using competition ELISA. We then assessed the association between the antibody levels, function, and CHMI defined clinical outcome during a 21-day follow-up period post infection using Cox proportional hazards regression.Results: Antibody levels to the individual isolate VSAs, or to two ICAM1-binding DBLβ domains of PfEMP1, were not associated with a significantly reduced risk of developing parasitemia or of meeting treatment criteria after the challenge after adjusting for exposure. However, anti-VSA antibody breadth (i.e., cumulative response to all the isolates) was a significant predictor of reduced risk of requiring treatment [HR 0.23 (0.10-0.50) p= 0.0002].Conclusion: The breadth of IgG antibodies to VSAs, but not to individual isolate VSAs, is associated with protection in CHMI.
- Open Access
- 22 December 2020
- Published by F1000 Research Ltd in AAS Open Research
- Vol. 3, 51
Developing excellence in biostatistics leadership, training and science in Africa: How the Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) training unites expertise to deliver excellence
The increase in health research in sub-Saharan Africa (SSA) has led to a high demand for biostatisticians to develop study designs, contribute and apply statistical methods in data analyses. Initiatives exist to address the dearth in statistical capacity and lack of local biostatisticians in SSA health projects. The Sub-Saharan African Consortium for Advanced Biostatistics (SSACAB) led by African institutions was initiated to improve biostatistical capacity according to the needs identified by African institutions, through collaborative masters and doctoral training in biostatistics. SACCAB has created a critical mass of biostatisticians and a network of institutions over the last five years and has strengthened biostatistics resources and capacity for health research studies in SSA. SSACAB comprises 11 universities and four research institutions which are supported by four European universities. In 2015, only four universities had established Masters programmes in biostatistics and SSACAB supported the remaining seven to develop Masters programmes. In 2019 the University of the Witwatersrand became the first African institution to gain Royal Statistical Society accreditation for a Biostatistics Masters programme. A total of 150 fellows have been awarded scholarships to date of which 123 are Masters fellowships (41 female) of whom 58 have already graduated. Graduates have been employed in African academic (19) and research (15) institutions and 10 have enrolled for PhD studies. A total of 27 (10 female) PhD fellowships have been awarded; 4 of them are due to graduate by 2020. To date, SSACAB Masters and PhD students have published 17 and 31 peer-reviewed articles, respectively. SSACAB has also facilitated well-attended conferences, face-to-face and online short courses. Pooling of limited biostatistics resources in SSA combined with co-funding from external partners has shown to be an effective strategy for the development and teaching of advanced biostatistics methods, supervision and mentoring of PhD candidates.
- 22 December 2020
- Published by F1000 Research Ltd in AAS Open Research
- Vol. 3, 51
Open AccessDeveloping excellence in biostatistics leadership, training and science in Africa: How the Sub-Saharan Africa Consortium for Advanced Biostatistics (SSACAB) training unites expertise to deliver excellence
The increase in health research in sub-Saharan Africa (SSA) has led to a high demand for biostatisticians to develop study designs, contribute and apply statistical methods in data analyses. Initiatives exist to address the dearth in statistical capacity and lack of local biostatisticians in SSA health projects. The Sub-Saharan African Consortium for Advanced Biostatistics (SSACAB) led by African institutions was initiated to improve biostatistical capacity according to the needs identified by African institutions, through collaborative masters and doctoral training in biostatistics. SACCAB has created a critical mass of biostatisticians and a network of institutions over the last five years and has strengthened biostatistics resources and capacity for health research studies in SSA. SSACAB comprises 11 universities and four research institutions which are supported by four European universities. In 2015, only four universities had established Masters programmes in biostatistics and SSACAB supported the remaining seven to develop Masters programmes. In 2019 the University of the Witwatersrand became the first African institution to gain Royal Statistical Society accreditation for a Biostatistics Masters programme. A total of 150 fellows have been awarded scholarships to date of which 123 are Masters fellowships (41 female) of whom 58 have already graduated. Graduates have been employed in African academic (19) and research (15) institutions and 10 have enrolled for PhD studies. A total of 27 (10 female) PhD fellowships have been awarded; 4 of them are due to graduate by 2020. To date, SSACAB Masters and PhD students have published 17 and 31 peer-reviewed articles, respectively. SSACAB has also facilitated well-attended conferences, face-to-face and online short courses. Pooling of limited biostatistics resources in SSA combined with co-funding from external partners has shown to be an effective strategy for the development and teaching of advanced biostatistics methods, supervision and mentoring of PhD candidates.
- Open Access
- 6 July 2020
- Published by BMJ in BMJ Global Health
- Vol. 5 (7) , e003072
Enhancing science preparedness for health emergencies in Africa through research capacity building
- 6 July 2020
- Published by BMJ in BMJ Global Health
- Vol. 5 (7) , e003072
Open AccessEnhancing science preparedness for health emergencies in Africa through research capacity building
- Open Access
- 6 September 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (9) , eaax4489
IgM in human immunity to Plasmodium falciparum malaria
Most studies on human immunity to malaria have focused on the roles of immunoglobulin G (IgG), whereas the roles of IgM remain undefined. Analyzing multiple human cohorts to assess the dynamics of malaria-specific IgM during experimentally induced and naturally acquired malaria, we identified IgM activity against blood-stage parasites. We found that merozoite-specific IgM appears rapidly in Plasmodium falciparum infection and is prominent during malaria in children and adults with lifetime exposure, together with IgG. Unexpectedly, IgM persisted for extended periods of time; we found no difference in decay of merozoite-specific IgM over time compared to that of IgG. IgM blocked merozoite invasion of red blood cells in a complement-dependent manner. IgM was also associated with significantly reduced risk of clinical malaria in a longitudinal cohort of children. These findings suggest that merozoite-specific IgM is an important functional and long-lived antibody response targeting blood-stage malaria parasites that contributes to malaria immunity.
- 6 September 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (9) , eaax4489
Open AccessIgM in human immunity to Plasmodium falciparum malaria
Most studies on human immunity to malaria have focused on the roles of immunoglobulin G (IgG), whereas the roles of IgM remain undefined. Analyzing multiple human cohorts to assess the dynamics of malaria-specific IgM during experimentally induced and naturally acquired malaria, we identified IgM activity against blood-stage parasites. We found that merozoite-specific IgM appears rapidly in Plasmodium falciparum infection and is prominent during malaria in children and adults with lifetime exposure, together with IgG. Unexpectedly, IgM persisted for extended periods of time; we found no difference in decay of merozoite-specific IgM over time compared to that of IgG. IgM blocked merozoite invasion of red blood cells in a complement-dependent manner. IgM was also associated with significantly reduced risk of clinical malaria in a longitudinal cohort of children. These findings suggest that merozoite-specific IgM is an important functional and long-lived antibody response targeting blood-stage malaria parasites that contributes to malaria immunity.